Tedizolid Phosphate — Active Pharmaceutical Ingredient

Tedizolid Phosphate is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: TABLET, POWDER. Routes: ORAL, INTRAVENOUS.

This content is for informational purposes only. Always consult a healthcare professional.

Tedizolid Phosphate (1 brand name, 2 dosage forms, 2 routes)

Available dosage forms: TABLET, POWDER.

Routes of administration: ORAL, INTRAVENOUS.

Brand Names

  • SIVEXTRO

Contraindications

None.

Adverse Reactions

The following clinically significant adverse reactions are described elsewhere in the labeling: Serotonin Syndrome [see Warnings and Precautions (5.1)] Clostridioides difficile-Associated Diarrhea [see Warnings and Precautions (5.3)]

Mechanism of Action

Tedizolid is an antibacterial drug [see Microbiology (12.4)].

Overdosage

In the event of overdosage, SIVEXTRO should be discontinued and general supportive treatment given. Hemodialysis does not result in meaningful removal of tedizolid from systemic circulation.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.